The following is a list of systematic reviews published by Cochrane Urology, organized by condition. Each title links to the full review on the Cochrane Library.
Bladder cancer (urothelial carcinoma)
- Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
- Alvimopan for recovery of bowel function after radical cystectomy
- Blue versus white light for transurethral resection of non-muscle invasive bladder cancer
- En bloc versus standard transurethral resection of bladder tumors for non-muscle-invasive bladder cancer patients
- En-bloc resection versus conventional transurethral resection for patients with non-muscle-invasive bladder cancer
- Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in people undergoing radical cystectomy
- Gemcitabine for unresectable, locally advanced or metastatic bladder cancer
- Immunotherapy for advanced or metastatic urothelial carcinoma
- Intravesical Bacillus Calmette-Guérin in Ta and T1 bladder cancer
- Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer
- Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
- Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer
- Intravesical electromotive drug administration for non-muscle invasive bladder cancer
- Intravesical gemcitabine for non-muscle invasive bladder cancer
- Intravesical therapy for non-muscle invasive bladder cancer: a network meta-analysis
- Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer
- Neo-adjuvant chemotherapy for invasive bladder cancer
- Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review
- Perioperative nutrition for the treatment of bladder cancer by radical cystectomy
- Perioperative systemic chemo-immunotherapy for upper urinary tract urothelial carcinoma
- Robotic versus open radical cystectomy for bladder cancer in adults
- Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma
- Surgery versus radiotherapy for muscle invasive bladder cancer
- Surgical management for upper urinary tract transitional cell carcinoma
Prostate cancer
- 5-alpha-reductase inhibitors for prostate cancer prevention
- Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer
- Adjuvant radiotherapy following radical prostatectomy for prostate cancer
- Antibiotic prophylaxis for transrectal prostate biopsy
- Bisphosphonates for advanced prostate cancer
- Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis
- Chemoprevention agents for prostate cancer
- Chemotherapy for hormone-refractory prostate cancer
- Degarelix for treating advanced hormone-sensitive prostate cancer
- Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer
- Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer
- Hypofractionation for clinically localized prostate cancer
- Intermittent versus continuous androgen suppression for prostatic cancer
- Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer
- Low-dose rate brachytherapy for men with localized prostate cancer
- Lycopene for the prevention of prostate cancer
- Maximal androgen blockade for advanced prostate cancer
- Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
- Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer
- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy
- Posterior musculofascial reconstruction in robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer
- Prediction of disease specific and overall survival in men with prostate cancer using the Decipher assay
- Primary cryotherapy for localised or locally advanced prostate cancer
- Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer
- Psychosocial interventions for men with prostate cancer
- Radical prostatectomy versus deferred treatment for localised prostate cancer
- Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer
- Screening for prostate cancer
- Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer
Benign prostatic hyperplasia and lower urinary tract symptoms
- 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction
- Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction
- Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Beta-sitosterols for benign prostatic hyperplasia
- Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction
- Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia
- Desmopressin for treating nocturia in men
- Finasteride for benign prostatic hyperplasia
- Holmium laser enucleation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Laser prostatectomy for benign prostatic obstruction
- Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis
- Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
- Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
- Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction
- Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Pygeum africanum for benign prostatic hyperplasia
- Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement
- Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
Renal cancer
- Cytoreductive nephrectomy in metastatic renal cell carcinoma
- First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis
- Image-guided percutaneous renal core biopsy of small renal masses to diagnose renal cancer
- Immunotherapy for metastatic renal cell carcinoma
- Partial nephrectomy versus radical nephrectomy for clinical localised renal masses
- Targeted therapy for advanced renal cell carcinoma
- Targeted therapy for metastatic renal cell carcinoma
Urinary stones
- Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults
- Alpha-blockers as medical expulsive therapy for ureteral stones
- Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones
- Medical and dietary interventions for preventing recurrent urinary stones in children
- Medical and surgical interventions for the treatment of urinary stones in children
- Percutaneous nephrolithotomy versus retrograde intrarenal surgery for treatment of renal stones in adults
- Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones
- Tranexamic acid for percutaneous nephrolithotomy
- Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi
- Ureteroscopic thulium versus holmium laser fragmentation for renal and ureteral stones in adults
- Water for preventing urinary stones
Sexual health and erectile dysfunction
- Apomorphine for the treatment of erectile dysfunction
- Ginseng for erectile dysfunction
- Low-intensity shockwave therapy for erectile dysfunction
- Non-surgical therapies for Peyronie's disease
- Penile rehabilitation for postprostatectomy erectile dysfunction
- Psychosocial interventions for erectile dysfunction
- Psychosocial interventions for premature ejaculation
- Selective serotonin re-uptake inhibitors for premature ejaculation in adult men
Prostatitis and chronic pelvic pain syndrome
- Allopurinol for chronic prostatitis
- Antimicrobial therapy for chronic bacterial prostatitis
- Interventions for chronic abacterial prostatitis
- Interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- Pregabalin for chronic prostatitis
Other urologic conditions and procedures
- Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy
- Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions
- Screening for testicular cancer
- Surgery versus non-surgical management for unilateral ureteric-pelvic junction obstruction in newborns and infants less than two years of age
- Topical corticosteroids for treating phimosis in boys